Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001144204-12-025539)

Filing Details

Accession Number:: 0001144204-12-025539
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-05-02 13:14:21
Reporting Period:: 2012-04-30

Filing Date:: 2012-05-02
Accepted Time:: 2012-05-02 13:14:21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1077183	Neogenomics Inc	NGNM.OB	Services-Testing Laboratories (8734)	742897368

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1518888	T Michael Dent	12701 Commonwealth Drive Suite 9 Fort Myers FL US 33913		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-04-30	15,602	$1.70	1,603,050	No	4	S	Indirect	Held in trust by spouse

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Held in trust by spouse

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	24,000	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock option (Right to buy)	$0.25	2004-08-14	2014-08-13	0	400,000	Direct
Common Stock	Warrant (Right to buy)	$1.50	2007-06-07	2012-06-06	0	100,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2014-08-13	0	400,000	Direct
2012-06-06	0	100,000	Direct

Footnotes

On April 27,2011 the Board of Directors approved and granted a restricted stock award of 24,000 shares of NeoGenomics common stock. The terms of the award call for 2,000 shares to vest on the last day of the next 12 quarters starting on June 30, 2011 as long as Mr. Dent remains a Director of the Company.